GeneDx Holdings Corp. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
GeneDx Holdings Corp. (WGS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $6.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-03
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $6.34M, a 18.83% decline year-over-year.
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $9.00M, a 125.86% increase year-over-year.
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $9.78M, a 243.76% increase year-over-year.
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $10.59M, a 191.14% increase year-over-year.
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $32.16M, a 251.96% increase from fiscal 2024.
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $9.14M.
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was -$326.00K, a 100.78% decline from fiscal 2022.
- GeneDx Holdings Corp. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $41.98M, a 0.97% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.34M 10-Q · filed 2026-08-03 | $15.34M 10-Q · filed 2026-08-03 | $25.12M derived: sum of 3 quarters · filed 2026-08-03 | $35.70M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $9.00M 10-Q · filed 2026-05-04 | $18.78M derived: sum of 2 quarters · filed 2026-05-04 | $29.36M derived: sum of 3 quarters · filed 2026-05-04 | $37.17M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $20.37M derived: sum of 2 quarters · filed 2026-02-23 | $28.18M derived: sum of 3 quarters · filed 2026-08-03 | $32.16M 10-K · filed 2026-02-23 | ||
| 2025-09-30 | $10.59M 10-Q · filed 2025-10-28 | $18.40M derived: sum of 2 quarters · filed 2026-08-03 | $22.38M 10-Q · filed 2025-10-28 | $25.23M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $7.81M 10-Q · filed 2026-08-03 | $11.80M 10-Q · filed 2026-08-03 | $14.64M derived: sum of 3 quarters · filed 2026-08-03 | $18.28M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $3.98M 10-Q · filed 2026-05-04 | $6.83M derived: sum of 2 quarters · filed 2026-05-04 | $10.46M derived: sum of 3 quarters · filed 2026-05-04 | $13.57M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $6.48M derived: sum of 2 quarters · filed 2026-02-23 | $9.59M derived: sum of 3 quarters · filed 2026-02-23 | $9.14M 10-K · filed 2026-02-23 | ||
| 2024-09-30 | $3.64M 10-Q · filed 2025-10-28 | $6.74M derived: sum of 2 quarters · filed 2025-10-28 | $6.29M 10-Q · filed 2025-10-28 | $5.38M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-30 | $3.11M 10-Q · filed 2025-07-29 | $2.66M 10-Q · filed 2025-07-29 | $1.75M derived: sum of 3 quarters · filed 2026-02-23 | $2.18M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | -$451.00K 10-Q · filed 2025-04-30 | -$1.36M derived: sum of 2 quarters · filed 2026-02-23 | -$932.00K derived: sum of 3 quarters · filed 2026-02-23 | -$825.00K derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | -$912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$481.00K derived: sum of 2 quarters · filed 2026-02-23 | -$374.00K derived: sum of 3 quarters · filed 2026-02-23 | -$326.00K 10-K · filed 2026-02-23 | ||
| 2023-09-30 | $431.00K 10-Q · filed 2024-10-29 | $538.00K derived: sum of 2 quarters · filed 2024-10-29 | $586.00K 10-Q · filed 2024-10-29 | $1.01M derived: sum of 4 quarters · filed 2024-10-29 | ||
| 2023-06-30 | $107.00K 10-Q · filed 2024-07-30 | $156.00K 10-Q · filed 2024-07-30 | $155.00K 10-Q · filed 2023-08-08 | $577.00K derived: sum of 3 quarters · filed 2024-07-30 | $1.85M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-03-31 | $48.00K 10-Q · filed 2024-04-29 | $470.00K derived: sum of 2 quarters · filed 2024-04-29 | $1.74M derived: sum of 3 quarters · filed 2024-04-29 | $24.46M derived: sum of 4 quarters · filed 2024-04-29 | ||
| 2022-12-31 | $422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.69M derived: sum of 2 quarters · filed 2024-02-23 | $24.41M derived: sum of 3 quarters · filed 2024-02-23 | $41.98M 10-K · filed 2024-02-23 | ||
| 2022-09-30 | $1.27M 10-Q · filed 2023-11-03 | $23.99M derived: sum of 2 quarters · filed 2023-11-03 | $41.55M 10-Q · filed 2023-11-03 | $41.55M 10-Q · filed 2022-11-14 | $78.52M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $22.72M 10-Q · filed 2023-08-08 | $40.28M 10-Q · filed 2023-08-08 | $77.25M derived: sum of 3 quarters · filed 2023-08-08 | $82.67M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $17.56M 10-Q · filed 2023-05-09 | $54.53M derived: sum of 2 quarters · filed 2023-05-09 | $59.94M derived: sum of 3 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $36.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $42.38M derived: sum of 2 quarters · filed 2023-03-16 | $42.38M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $5.42M 10-Q · filed 2022-11-14 | $5.42M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |